Japanese clinical practice guidelines for oral cancer, 2023

H. Kurita; N. Uzawa; H. Nakayama; T. Abe; S. Ibaraki; Y. Ohyama; K. Uchida; H. Sato; S. Miyabe; T. Abé; N. Kakimoto; A. Kaida; T. Sugiura; M. Kioi; A. Danjo; N. Kitamura; O. Hasegawa; T. Tanaka; N. Ueda; T. Hasegawa; S. Asoda; H. Katsuta; S. Yanamoto; S. Yamada; D. Takeda; T. Suzuki; Y. Ohta; T. Kirita

doi:10.1016/j.ijom.2024.11.012

Japanese clinical practice guidelines for oral cancer, 2023

H. Kurita, N. Uzawa, H. Nakayama, T. Abe, S. Ibaraki, Y. Ohyama, K. Uchida, H. Sato, S. Miyabe, T. Abé, N. Kakimoto, A. Kaida, T. Sugiura, M. Kioi, A. Danjo, N. Kitamura, O. Hasegawa, T. Tanaka, N. Ueda, T. HasegawaS. Asoda, H. Katsuta, S. Yanamoto, S. Yamada, D. Takeda, T. Suzuki, Y. Ohta, T. Kirita

School of Dentistry

Research output: Contribution to journal › Review article › peer-review

Abstract

The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

Original language	English
Pages (from-to)	461-476
Number of pages	16
Journal	International Journal of Oral and Maxillofacial Surgery
Volume	54
Issue number	5
DOIs	https://doi.org/10.1016/j.ijom.2024.11.012
Publication status	Published - May 2025

Keywords

Diagnosis
Mouth neoplasms
Patient care
Practice guideline
Therapeutics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijom.2024.11.012

Cite this

Kurita, H., Uzawa, N., Nakayama, H., Abe, T., Ibaraki, S., Ohyama, Y., Uchida, K., Sato, H., Miyabe, S., Abé, T., Kakimoto, N., Kaida, A., Sugiura, T., Kioi, M., Danjo, A., Kitamura, N., Hasegawa, O., Tanaka, T., Ueda, N., ... Kirita, T. (2025). Japanese clinical practice guidelines for oral cancer, 2023. International Journal of Oral and Maxillofacial Surgery, 54(5), 461-476. https://doi.org/10.1016/j.ijom.2024.11.012

@article{f4981e3c05444672876cc4eee672711c,

title = "Japanese clinical practice guidelines for oral cancer, 2023",

abstract = "The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.",

keywords = "Diagnosis, Mouth neoplasms, Patient care, Practice guideline, Therapeutics",

author = "H. Kurita and N. Uzawa and H. Nakayama and T. Abe and S. Ibaraki and Y. Ohyama and K. Uchida and H. Sato and S. Miyabe and T. Ab{\'e} and N. Kakimoto and A. Kaida and T. Sugiura and M. Kioi and A. Danjo and N. Kitamura and O. Hasegawa and T. Tanaka and N. Ueda and T. Hasegawa and S. Asoda and H. Katsuta and S. Yanamoto and S. Yamada and D. Takeda and T. Suzuki and Y. Ohta and T. Kirita",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2025",

month = may,

doi = "10.1016/j.ijom.2024.11.012",

language = "English",

volume = "54",

pages = "461--476",

journal = "International Journal of Oral and Maxillofacial Surgery",

issn = "0901-5027",

publisher = "Churchill Livingstone",

number = "5",

}

Kurita, H, Uzawa, N, Nakayama, H, Abe, T, Ibaraki, S, Ohyama, Y, Uchida, K, Sato, H, Miyabe, S, Abé, T, Kakimoto, N, Kaida, A, Sugiura, T, Kioi, M, Danjo, A, Kitamura, N, Hasegawa, O, Tanaka, T, Ueda, N, Hasegawa, T, Asoda, S, Katsuta, H, Yanamoto, S, Yamada, S, Takeda, D, Suzuki, T, Ohta, Y & Kirita, T 2025, 'Japanese clinical practice guidelines for oral cancer, 2023', International Journal of Oral and Maxillofacial Surgery, vol. 54, no. 5, pp. 461-476. https://doi.org/10.1016/j.ijom.2024.11.012

TY - JOUR

T1 - Japanese clinical practice guidelines for oral cancer, 2023

AU - Kurita, H.

AU - Uzawa, N.

AU - Nakayama, H.

AU - Abe, T.

AU - Ibaraki, S.

AU - Ohyama, Y.

AU - Uchida, K.

AU - Sato, H.

AU - Miyabe, S.

AU - Abé, T.

AU - Kakimoto, N.

AU - Kaida, A.

AU - Sugiura, T.

AU - Kioi, M.

AU - Danjo, A.

AU - Kitamura, N.

AU - Hasegawa, O.

AU - Tanaka, T.

AU - Ueda, N.

AU - Hasegawa, T.

AU - Asoda, S.

AU - Katsuta, H.

AU - Yanamoto, S.

AU - Yamada, S.

AU - Takeda, D.

AU - Suzuki, T.

AU - Ohta, Y.

AU - Kirita, T.

PY - 2025/5

Y1 - 2025/5

N2 - The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

AB - The Japanese Society of Oral Oncology and Japanese Society of Oral and Maxillofacial Surgeons have jointly developed clinical practice guidelines for oral cancer (oral squamous cell carcinoma) to improve and standardize the quality of oral cancer treatment in Japan. The first, second, and third editions were published in 2009, 2013, and 2019, respectively, and the 2023 edition was recently developed. In the development of the 2023 edition, 60 clinical questions (CQs) were listed. Systematic reviews following the GRADE approach were performed for 11 of these CQs. This article outlines the 2023 edition and describes the most relevant guidelines and CQs for the diagnosis, treatment, follow-up, and supportive care of oral cancer patients in Japan.

KW - Diagnosis

KW - Mouth neoplasms

KW - Patient care

KW - Practice guideline

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85213017898&partnerID=8YFLogxK

U2 - 10.1016/j.ijom.2024.11.012

DO - 10.1016/j.ijom.2024.11.012

M3 - Review article

C2 - 39721909

AN - SCOPUS:85213017898

SN - 0901-5027

VL - 54

SP - 461

EP - 476

JO - International Journal of Oral and Maxillofacial Surgery

JF - International Journal of Oral and Maxillofacial Surgery

IS - 5

ER -

Japanese clinical practice guidelines for oral cancer, 2023

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this